Labstyle receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DarioHealth Corp (DRIO)
DarioHealth Corp stock price live, this page displays NASDAQ DRIO stock exchange data. View the DRIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DarioHealth Corp real time stock price chart below.
What Is the DarioHealth Corp Stock Price Today?
The DarioHealth Corp stock price today is 7.990.
What Is the Stock Symbol for DarioHealth Corp?
The stock symbol for DarioHealth Corp is "DRIO."
What Stock Exchange Does DarioHealth Corp Trade On?
DarioHealth Corp is listed and trades on the NASDAQ stock exchange.
Is DarioHealth Corp a Good Stock to Buy?
Determining whether DarioHealth Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRIO quote. (ISIN: US23725P3082)
What Is the DarioHealth Corp Stock Price Today?
The DarioHealth Corp stock price today is 7.990.
What Is the Stock Symbol for DarioHealth Corp?
The stock symbol for DarioHealth Corp is "DRIO."
What Stock Exchange Does DarioHealth Corp Trade On?
DarioHealth Corp is listed and trades on the NASDAQ stock exchange.
Is DarioHealth Corp a Good Stock to Buy?
Determining whether DarioHealth Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRIO quote. (ISIN: US23725P3082)
7.990
-0.250(-3.03%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.870
8.100
52 wk Range
5.935
17.744
DRIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.8708.100
52 wk Range
5.93517.744
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DRIO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
18.800
Upside
+135.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Form S-3 DarioHealth Corp For: 19 March
- Investing.com
- Labstyle receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form S-3 DarioHealth Corp For: 19 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
DarioHealth Corp Earnings Call Summary for Q4/2025
- DarioHealth's 2025 revenue fell 17% to $22.4M due to legacy client non-renewal; Q4 showed sequential growth to $5.2M with 2% stock gain after-hours.
- Gross margin expanded 800 basis points to 57% in 2025; operating expenses cut 31% to $49.3M, improving operating loss by $21M year-over-year.
- Company pivoting to multi-condition digital care platforms with AI-driven efficiencies to enhance competitive positioning and reduce operational costs.
- Management expects 2026 revenue growth from new client wins and contract ramp-ups, with strongest acceleration anticipated in second half of year.
- Key risks include client non-renewals, digital health competition, AI integration execution, economic healthcare spending pressures, and regulatory changes.
Last Updated: 2026-03-19, 09:26 a/m
Read Full TranscriptCompare DRIO to Peers and Sector
Metrics to compare | DRIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDRIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −0.5x | −0.5x | |
PEG Ratio | −0.09 | −0.01 | 0.00 | |
Price/Book | 0.8x | 1.1x | 2.6x | |
Price / LTM Sales | 2.4x | 0.9x | 3.1x | |
Upside (Analyst Target) | 150.3% | 54.5% | 57.6% | |
Fair Value Upside | Unlock | 39.2% | 8.6% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.800
(+135.29% Upside)
Earnings
Latest Release
Mar 19, 2026
EPS / Forecast
-2.21 / -0.18
Revenue / Forecast
5.23M / 9.84M
People Also Watch
FAQ
What Is the DarioHealth (DRIO) Stock Price Today?
The DarioHealth stock price today is 7.990 USD.
What Stock Exchange Does DarioHealth Trade On?
DarioHealth is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for DarioHealth?
The stock symbol for DarioHealth is "DRIO."
What Is the DarioHealth Market Cap?
As of today, DarioHealth market cap is 54.000M USD.
What Is DarioHealth's Earnings Per Share (TTM)?
The DarioHealth EPS (TTM) is -10.473.
When Is the Next DarioHealth Earnings Date?
DarioHealth will release its next earnings report on Nov 13, 2025.
From a Technical Analysis Perspective, Is DRIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has DarioHealth Stock Split?
DarioHealth has split 4 times.
How Many Employees Does DarioHealth Have?
DarioHealth has 199 employees.
What is the current trading status of DarioHealth (DRIO)?
As of Mar 21, 2026, DarioHealth (DRIO) is trading at a price of 7.990 USD, with a previous close of 8.240 USD. The stock has fluctuated within a day range of 7.870 USD to 8.100 USD, while its 52-week range spans from 5.935 USD to 17.744 USD.
What Is DarioHealth (DRIO) Price Target According to Analysts?
The average 12-month price target for DarioHealth is 18.800 USD, with a high estimate of 28 USD and a low estimate of 10 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +135.29% Upside potential.
What Is the DRIO After Hours Price?
DRIO's last after hours stock price is 7.610 USD, the stock has decreased by -0.630, or -7.650%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.